BRS1-1-4 - Noradrenergic Signalling
(Attention & Executive Modulation)
1. Mission & Overview
Mission
Support noradrenergic alertness and executive control so attention and arousal stay appropriately engaged.
Intervention Dominance: Diet-Supported
- Iron
- Pyridoxal 5′-phosphate (PLP; active vitamin B6 cofactor)
- Vitamin B6
- Copper
- Vitamin C (ascorbate)
- Iron
- Pyridoxal 5′-phosphate (PLP; active vitamin B6 cofactor)
- Monoamine precursor supply
Individual KC inputs
-
Tyrosine
-
Phenylalanine
-
Methyl-resource supply for COMT
Individual KC inputs
- Vitamin B9 (folate)
- Betaine
- Choline
Overview
Noradrenaline, also called norepinephrine, helps set arousal, vigilance and executive control so attention can stay engaged. [1] Neurons make it from dopamine, then shape the signal through release, receptors, reuptake and breakdown. [9] [10] This coordination lets alertness follow cognitive demand. [1] Iron, vitamin B6, copper and vitamin C take part in that chemistry. [3] [7] [12] [13]
- Benefits: Noradrenaline helps keep arousal and vigilance matched to cognitive demand. [1]
- Implementation Notes: Iron, vitamin B6, copper, and vitamin C are the cofactors on the path from dopamine to noradrenaline. [3] [7] [12] [13] Extra intake when status is already adequate is not established to raise brain noradrenaline or improve attention. [1] [4]
- Biological Relevance: This tunes alert engagement rather than creating the precursor pool. [2]
2. Primary Biological Effects
↑ norepinephrine signalling; ↑ attention; ↑ executive modulation
3. Intervention Levers
Only categories with a substantive evidence-qualified intervention are shown.
No evidence-qualified lifestyle relationship is projected. Exercise is not a Dietary Requirement of noradrenergic signalling.
4. Mechanistic Basis
Summary
Noradrenergic signalling relevant to attention, arousal and executive control depends on the tyrosine-derived catecholamine path and on cofactor context described under BRS1(FM1) — Monoaminergic Function. Physical activity, sleep and stress can also shape catecholamine tone; those relationships are not established here as dietary requirements.
(Noradrenergic pathways and attention)
Norepinephrine modulates attention, arousal, and executive processes frequently impaired in attention-related conditions. Alterations in noradrenergic signalling have been associated with differences in attention regulation and response inhibition → [O'Donnell et al., 2012]
(Firing, receptor actions and regional clearance)
Noradrenergic signalling depends on when neurons fire, which receptors respond and how transmitters are cleared. Monkey pharmacology supports alpha2-adrenergic and D1 contributions to prefrontal regulation Gamo, Wang and Arnsten (2010) [16]. Mouse experiments identify NET-mediated dopamine uptake in frontal cortex Morón et al. (2002) [17]. Locus-coeruleus recordings link phasic responses to attended cues Aston-Jones et al. (1994) [18]. These distinct experimental links support regulated signalling beyond synthesis; they do not establish dietary control or human ADHD benefit.
(Precursor and cofactor dependence)
Noradrenaline is formed from dopamine on the tyrosine-derived catecholamine path. Circulating tyrosine comes from the amino-acid pool described by BRS1-FM1-PM1 — Amino-Acid Availability & Prioritisation. Meal-level large-neutral-amino-acid transport is described by BRS1-FM1-PM2 — LAT1 Competitive Transport Modulation and Fernstrom (2013) [2]. Iron is required by tyrosine hydroxylase, the rate-limiting step from tyrosine toward dopamine and then noradrenaline Beard et al. (2003) [3]. Dopamine β-hydroxylase then converts dopamine to noradrenaline and requires copper and ascorbate Goldstein and Eisenhofer (2026) [9].
(Diet-supported rather than diet-dominant)
Meal-level substrate and cofactor supply sit beside physical activity, sleep and stress context. Those lifestyle relationships are not established here as dietary requirements.
(Cross-system context)
Catecholamine inactivation can involve COMT, which uses SAM from one-carbon metabolism. The attached corpus does not establish that methylation-cycle diet changes noradrenaline signalling. Glycaemic volatility can change arousal indirectly; that is not a noradrenaline dietary finding.
Together this mechanism extends catecholamine coverage from dopamine formation to noradrenergic attention and executive modulation.
4.1 Scientific Findings
Summary
Structural and biochemical evidence establishes copper and ascorbate participation in the defining dopamine-to-noradrenaline conversion. [10] [9] Animal pharmacology and neuronal recordings separately support receptor-dependent prefrontal regulation and firing-pattern responses to attended cues. [16] [18] These findings support distinct synthesis and signalling processes; they do not establish that changing dietary precursor or cofactor intake changes brain noradrenaline firing or attention.
Noradrenaline (norepinephrine) is a neuromodulator that changes how many brain-cell types respond, helping set arousal and vigilance so attention and executive control can stay engaged. That is a signalling role, not a dietary dosing rule.
What this means
This supports the mechanism’s attention and arousal mission. It does not show that changing food intake raises brain noradrenaline or treats ADHD.
Evidence confidence: Not yet scored
Finding ID: PM4-F1
Finding Statement: Noradrenaline modulates arousal, vigilance and executive-control processes by changing the gain of multiple central-nervous-system cell types rather than acting as a single directional attention chemical.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The attached review treats norepinephrine as a widespread neuromodulator that optimises central-nervous-system performance by acting on several cell types. That account matches the mission of supporting alertness and executive control. It does not measure dietary intake, brain noradrenaline after meals, or a clinical attention outcome.
Synthesis Limitations: The source is a mechanistic review, not a human dietary or ADHD trial. It does not isolate receptor subtypes, quantify everyday noradrenaline tone, or show that precursor or cofactor intake changes signalling.
Evidence Considered:
- Study
- Narrative review of norepinephrine as a multi-cell-type neuromodulator.
- Population
- Mixed experimental and human mechanistic literature; not a dietary intervention sample.
- Result
- Identified norepinephrine as a gain-setting neuromodulator rather than a single-target attention chemical.
- Effect / Magnitude
- No pooled functional or dietary effect estimate.
- Evidence Summary
- Establishes the signalling role this mechanism represents.
- Limitations
- Review synthesis; does not demonstrate dietary modification or a clinical attention benefit.
- Evidence Source
- Inherited repository evidence
- Reference
- [1]
Informs: Focus / Attention Stability; Motivation / Drive; Pleasure & Interest Capacity
Noradrenaline is formed from dopamine on the tyrosine-derived catecholamine path. Iron supports tyrosine hydroxylase, and pyridoxal-5′-phosphate (PLP; the active form of vitamin B6) supports decarboxylation toward dopamine. These shared steps are biological requirements, not proof that extra iron or B6 raises brain noradrenaline.
What this means
Tyrosine remains the pathway starting material. Circulating amino-acid supply, competitive brain entry and dopamine formation are earlier steps. The later conversion of dopamine to noradrenaline is assessed in the dopamine β-hydroxylase finding.
Evidence confidence: Not yet scored
Finding ID: PM4-F2
Finding Statement: Noradrenaline formation depends on the shared tyrosine-to-dopamine catecholamine sequence, including iron- and PLP-dependent enzyme steps; cofactor or substrate necessity is not evidence of intake-responsive human brain noradrenaline.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Iron-deficiency review evidence identifies iron as required for tyrosine hydroxylase, the rate-limiting step from tyrosine toward dopamine and then noradrenaline. B-vitamin review evidence places PLP in neurochemical decarboxylation, and a transport study shows that B6 vitamers can enter the central nervous system. Together they support shared pathway dependence. They do not show ordinary-diet control of human brain noradrenaline. The later dopamine β-hydroxylase step is assessed separately.
Synthesis Limitations: The most direct deficiency discussion is preclinical or developmental. The sources do not establish common inadequacy in a defined clinical population, responsiveness when status is already adequate, or an attention benefit mediated by noradrenaline.
Evidence Considered:
- Study
- Narrative review of iron deficiency, brain development and neurotransmitter systems.
- Population
- Mixed human developmental and experimental-animal literature.
- Result
- Identified iron as required for tyrosine hydroxylase and described catecholamine-system sensitivity under deficiency.
- Effect / Magnitude
- No human intake-to-noradrenaline effect estimate.
- Evidence Summary
- Supports iron as a shared catecholamine-synthesis cofactor relevant to noradrenaline formation.
- Limitations
- Predominantly deficiency and developmental evidence; not a human noradrenaline-dosing or attention trial.
- Evidence Source
- Inherited repository evidence
- Reference
- [3]
Connected / Supportive Evidence:
- Kennedy (2016) [7] — MechanisticWhy relevant: Reviews B-vitamin roles in neurochemical synthesis, including vitamin B6 as cofactor context for catecholamine formation.Why excluded from the primary synthesis: General B-vitamin review; it does not isolate aromatic L-amino-acid decarboxylase or show an intake-to-noradrenaline response.
- Spector (1978) [8] — Animal DataWhy relevant: Shows that B6 vitamers enter the central nervous system and contribute to the brain vitamin B6 pool.Why excluded from the primary synthesis: Rabbit transport study; it does not measure noradrenaline synthesis, release or function.
Evidence Dependency:
- The later dopamine-to-noradrenaline conversion is assessed in PM4-F4 rather than restated here.
Informs: Motivation / Drive
Dopamine β-hydroxylase hydroxylates dopamine to noradrenaline inside vesicles. The enzyme needs copper at its active sites and ascorbate as the electron donor that keeps that copper reduced. These are reaction requirements, not proof that extra dietary copper or vitamin C raises brain noradrenaline.
What this means
This finding identifies copper and vitamin C (ascorbate) as candidates for dietary assessment. It does not admit an intake-responsive noradrenaline lever or an attention benefit.
Evidence confidence: Not yet scored
Finding ID: PM4-F4
Finding Statement: Conversion of dopamine to noradrenaline by dopamine β-hydroxylase requires enzyme-bound copper and ascorbate as the electron donor; those biochemical requirements are not evidence of intake-responsive human brain noradrenaline or a functional benefit.
Synthesised Evidence Confidence: Not yet scored
Synthesis: A 2026 catecholamine review identifies dopamine β-hydroxylase as a copper-dependent monooxygenase that uses molecular oxygen and ascorbate to form noradrenaline, and states that this is the only catecholamine-synthesis step with a direct mechanistic ascorbate requirement. The human crystal structure shows two copper ions per subunit and two ascorbate-derived electrons per turnover. Brain-copper and brain-ascorbate reviews place the same cuproenzyme and reductant in central-nervous-system catecholamine chemistry, while noting that circulating copper is not brain copper. Together they establish the defining conversion and its participants. Genetic copper-trafficking disease, animal copper deficiency and high-dose intravenous vitamin C in septic shock are not ordinary-diet evidence.
Synthesis Limitations: The synthesis is mechanistic and review-level. It does not show that ordinary dietary copper or vitamin C changes human brain noradrenaline, attention or ADHD when status is already adequate.
Evidence Considered:
- Study
- Integrative review of catecholamine synthesis, storage, release, reuptake and metabolism.
- Population
- Mixed human physiological, clinical-pathophysiological and experimental literature; not a dietary trial sample.
- Result
- Identified copper and ascorbate as required participants in the dopamine-to-noradrenaline step and noted that this is the only catecholamine step with a direct ascorbate requirement.
- Effect / Magnitude
- No dietary or functional effect estimate.
- Evidence Summary
- Establishes the defining conversion and its cofactor chemistry.
- Limitations
- Review synthesis; disease and kinetic examples are not ordinary-diet interventions.
- Evidence Source
- Bounded external search
- Reference
- [9]
- Study
- Crystal structure of human dopamine β-hydroxylase at 2.9 Å.
- Population
- Structural biochemistry; not a human dietary sample.
- Result
- Confirmed two type-2 copper sites per subunit and ascorbate dependence of the monooxygenase class.
- Effect / Magnitude
- Structural, not a dose-response estimate.
- Evidence Summary
- Independently supports copper and ascorbate as reaction participants.
- Limitations
- Isolated-protein structure; does not measure diet, brain noradrenaline or function.
- Evidence Source
- Bounded external search
- Reference
- [10]
Connected / Supportive Evidence:
- Scheiber, Mercer and Dringen (2014) [11] — MechanisticWhy relevant: Reviews copper functions in brain, including dopamine β-hydroxylase, and distinguishes tightly regulated brain copper from circulating measures.Why excluded from the primary synthesis: Brain-copper review; it does not isolate a dietary copper-to-noradrenaline trial.
- Lutsenko et al. (2019) [12] — MixedWhy relevant: Reviews copper and the brain noradrenergic system, including Menkes copper-trafficking disease and animal dietary-deficiency effects on catecholamines.Why excluded from the primary synthesis: Disease and animal-deficiency evidence; not ordinary-diet modulation in copper-replete humans.
- Harrison and May (2009) [13] — MechanisticWhy relevant: Reviews high brain ascorbate and SVCT2 transport, including a role as reductant for dopamine β-hydroxylase.Why excluded from the primary synthesis: Transport and compartmentation review; it does not show that extra dietary vitamin C raises human brain noradrenaline.
Informs: Motivation / Drive
Prefrontal catecholamine regulation includes receptor-dependent actions and shared regional clearance, rather than separate linear precursor-to-transmitter pathways.
What this means
Noradrenergic regulation extends beyond precursor supply. These experiments do not establish nutritional modulation or a clinical treatment claim.
Evidence confidence: Not yet scored
Finding ID: PM4-F5
Finding Statement: Prefrontal catecholamine regulation includes receptor-dependent actions and shared regional clearance, rather than separate linear precursor-to-transmitter pathways.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Monkey pharmacological experiments implicate alpha2-adrenergic and D1 receptors in prefrontal regulation. Mouse uptake experiments establish a regional NET contribution to dopamine clearance. The studies test different links, not one replicated protocol.
Synthesis Limitations: Animal experiments; no nutrient manipulation, human ADHD outcome or universal transporter rule.
Evidence Considered:
- Study
- Monkey delayed-response behaviour and prefrontal neuronal recordings with pharmacological receptor blockade.
- Population
- Monkeys; pharmacological experiments.
- Result
- Moderate drug doses improved performance; alpha2 or D1 blockade prevented improvement, and neuronal effects were dose-dependent.
- Effect / Magnitude
- Context-specific experimental result; no dietary effect estimate.
- Evidence Summary
- Moderate drug doses improved performance; alpha2 or D1 blockade prevented improvement, and neuronal effects were dose-dependent.
- Limitations
- Animal pharmacology; no dietary exposure or human ADHD endpoint.
- Evidence Source
- Bounded external search
- Reference
- [16]
- Study
- Radiolabelled dopamine uptake in regional synaptosomes using transporter inhibitors and knockout mice.
- Population
- Wild-type and NET/DAT knockout mice.
- Result
- Frontal-cortex dopamine uptake depended primarily on NET; caudate and accumbens uptake depended primarily on DAT.
- Effect / Magnitude
- Context-specific experimental result; no dietary effect estimate.
- Evidence Summary
- Frontal-cortex dopamine uptake depended primarily on NET; caudate and accumbens uptake depended primarily on DAT.
- Limitations
- Ex vivo mouse uptake; developmental knockout effects and regional differences limit generalisation.
- Evidence Source
- Bounded external search
- Reference
- [17]
In a monkey vigilance task, locus-coeruleus neurons showed target-linked phasic activity that varied with performance.
What this means
Noradrenergic regulation extends beyond precursor supply. These experiments do not establish nutritional modulation or a clinical treatment claim.
Evidence confidence: Not yet scored
Finding ID: PM4-F6
Finding Statement: In a monkey vigilance task, locus-coeruleus neurons showed target-linked phasic activity that varied with performance.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Neuronal recordings support firing-pattern regulation as distinct from substrate provision. They do not establish that changing precursor intake changes firing or performance.
Synthesis Limitations: Association in four monkeys; no causal intervention or ordinary-diet inference.
Evidence Considered:
- Study
- Extracellular locus-coeruleus recordings during an oddball vigilance task.
- Population
- Four cynomolgus monkeys.
- Result
- Target-linked phasic responses weakened during poorer task performance.
- Effect / Magnitude
- Context-specific experimental result; no dietary effect estimate.
- Evidence Summary
- Target-linked phasic responses weakened during poorer task performance.
- Limitations
- Observational neuronal/task association; no manipulation proving causation and no dietary or ADHD trial.
- Evidence Source
- Bounded external search
- Reference
- [18]
Remethylation can replenish methionine for SAM synthesis; human COMT uses SAM to methylate noradrenaline.
What this means
This establishes the connected biochemical supply route, not a measured dietary effect on regional neural SAM or COMT clearance. BHMT is predominantly hepatic/renal; peripheral methionine contribution, local SAM synthesis, alternative supply and turnover vary by tissue. Donor inadequacy as a limiting constraint and benefit from extra intake in replete individuals remain unresolved.
Evidence confidence: Not yet scored
Finding ID: PM4-F8
Finding Statement: Remethylation can replenish methionine for SAM synthesis; human COMT uses SAM to methylate noradrenaline.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Verified BRS2 PM1/PM2/PM3 Findings establish folate-dependent remethylation, betaine/BHMT remethylation, choline-to-betaine provision and MAT substrate use. Lotta's recombinant human COMT work establishes the downstream methyl-transfer reaction. These successive reactions support upstream resource provision. They do not directly measure transfer of a dietary donor into regional neural SAM or a change in signalling.
Synthesis Limitations: This establishes the connected biochemical supply route, not a measured dietary effect on regional neural SAM or COMT clearance. BHMT is predominantly hepatic/renal; peripheral methionine contribution, local SAM synthesis, alternative supply and turnover vary by tissue. Donor inadequacy as a limiting constraint and benefit from extra intake in replete individuals remain unresolved.
Evidence Considered:
- Froese et al. (2019) [19] — Mechanistic — Establishes folate/B12 remethylation and placement before MAT synthesis; reviewed on PM1-F1.
- Obeid (2013) [20] — Mechanistic — Establishes betaine donation and choline provision in connected remethylation; reviewed on PM2-F1/F2.
- Bailey et al. (2021) [21] — Mechanistic — Establishes methionine and ATP use in human MAT2A; reviewed on PM3-F1.
- Evans et al. (2002) [22] — Cellular / Molecular — Human BHMT reaction identity; supports betaine-to-methionine provision, not dietary MAT responsiveness.
- Salvi and Gadda (2013) [23] — Cellular / Molecular — Choline oxidation through betaine aldehyde to betaine; supports route identity, not MAT flux.
- Study
- Kinetic characterisation of recombinant soluble and membrane-bound human COMT.
- Population
- Human proteins expressed in bacterial and insect-cell systems; not a dietary or in-vivo neural trial.
- Result
- Measured catecholamine methylation and SAM affinity of both enzyme forms.
- Effect / Magnitude
- Different SAM binding affinities; no dietary intake, brain supply or functional effect estimate.
- Evidence Summary
- Establishes SAM use during catecholamine methylation.
- Limitations
- Primary abstract inspected; full experimental methods/results not obtained. Does not attribute neural SAM supply or clearance changes to donor intake.
- Evidence Source
- Bounded external search
- Reference
- [24]
Evidence Dependency:
- BRS2 PM1-F1, PM2-F1/F2 and PM3-F1/F4 are reused for reaction identity, not counted as new independent dietary or brain-supply evidence. Lotta (1995) is reused across the dopamine and noradrenaline PMs; this is one enzyme dataset, not independent replication.
The reviewed LNAA pool supplies tyrosine upstream of noradrenaline synthesis.
What this means
Ordinary dietary LNAA changes do not establish uniform effects on catecholamine synthesis, regional signalling or benefit. The separately recorded competitive capacity-constraint proposition remains unresolved.
Evidence confidence: Not yet scored
Finding ID: PM4-F7
Finding Statement: The reviewed LNAA pool supplies tyrosine upstream of noradrenaline synthesis.
Synthesised Evidence Confidence: Not yet scored
Synthesis: LAT1 presentation supplies tyrosine for the upstream catecholamine pathway assessed in PM4-F2; dopamine is subsequently converted to noradrenaline by DBH as assessed in PM4-F4. Tyrosine is not the immediate DBH substrate.
Synthesis Limitations: Ordinary dietary LNAA changes do not establish uniform effects on catecholamine synthesis, regional signalling or benefit. The separately recorded competitive capacity-constraint proposition remains unresolved.
Evidence Considered:
- Study
- Review of LNAA transport, dietary precursor presentation and brain neurochemistry.
- Population
- Mixed experimental contexts; not a new human noradrenergic dietary trial.
- Result
- Tyrosine availability and competing LNAA context are relevant to brain precursor supply.
- Effect / Magnitude
- No universal limiting intake or regional signalling response established.
- Evidence Summary
- Supports upstream presentation of tyrosine, with separate synthesis and functional boundaries.
- Limitations
- Review; source-linked reaction identity is reused from existing local synthesis Findings. Does not establish a new competitive capacity constraint or benefit from increased intake.
- Evidence Source
- Inherited repository evidence
- Reference
- [2]
Evidence Dependency:
- Fernstrom (2013) and the existing local synthesis Findings are reused for transport/precursor identity, not independent dietary efficacy evidence.
Phenylalanine can replenish circulating tyrosine upstream of noradrenaline synthesis; precursor conversion is not evidence that additional intake increases neuronal output.
What this means
Human peripheral conversion supplies circulating tyrosine; neuronal delivery uses the separately supported transport chain. This does not establish increased dopamine/noradrenaline output, a limiting intake or benefit from extra phenylalanine. Hydroxylation, renal/hepatic function and LNAA competition matter; high phenylalanine is not interchangeable with tyrosine.
Evidence confidence: Not yet scored
Finding ID: PM4-F9
Finding Statement: Phenylalanine can replenish circulating tyrosine upstream of noradrenaline synthesis; precursor conversion is not evidence that additional intake increases neuronal output.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Phenylalanine can replenish circulating tyrosine upstream of noradrenaline synthesis; precursor conversion is not evidence that additional intake increases neuronal output.
Synthesis Limitations: Human peripheral conversion supplies circulating tyrosine; neuronal delivery uses the separately supported transport chain. This does not establish increased dopamine/noradrenaline output, a limiting intake or benefit from extra phenylalanine. Hydroxylation, renal/hepatic function and LNAA competition matter; high phenylalanine is not interchangeable with tyrosine.
Evidence Considered:
- Study
- Organ-balance stable-isotope study
- Population
- 12 healthy subjects with renal sampling; separate splanchnic comparison
- Result
- Measured phenylalanine-to-tyrosine conversion and renal tyrosine release.
- Effect / Magnitude
- No general dietary efficacy or tissue-uniform effect is inferred.
- Evidence Summary
- Measured phenylalanine-to-tyrosine conversion and renal tyrosine release.
- Limitations
- Human peripheral conversion supplies circulating tyrosine; neuronal delivery uses the separately supported transport chain. This does not establish increased dopamine/noradrenaline output, a limiting intake or benefit from extra phenylalanine. Hydroxylation, renal/hepatic function and LNAA competition matter; high phenylalanine is not interchangeable with tyrosine. Evidence access: Primary abstract.
- Evidence Source
- Bounded external search
- Reference
- [25]
- Study
- Precursor administration and brain DOPA accumulation after decarboxylase inhibition
- Population
- Rats
- Result
- A low phenylalanine dose raised brain tyrosine without accelerating DOPA synthesis.
- Effect / Magnitude
- No general dietary efficacy or tissue-uniform effect is inferred.
- Evidence Summary
- A low phenylalanine dose raised brain tyrosine without accelerating DOPA synthesis.
- Limitations
- Human peripheral conversion supplies circulating tyrosine; neuronal delivery uses the separately supported transport chain. This does not establish increased dopamine/noradrenaline output, a limiting intake or benefit from extra phenylalanine. Hydroxylation, renal/hepatic function and LNAA competition matter; high phenylalanine is not interchangeable with tyrosine. Evidence access: Primary abstract.
- Evidence Source
- Bounded external search
- Reference
- [26]
- Study
- Review of LNAA transport, dietary precursor presentation and brain neurochemistry.
- Population
- Mixed experimental contexts; not a new human noradrenergic dietary trial.
- Result
- Tyrosine availability and competing LNAA context are relevant to brain precursor supply.
- Effect / Magnitude
- No universal limiting intake or regional signalling response established.
- Evidence Summary
- Supports upstream presentation of tyrosine, with separate synthesis and functional boundaries.
- Limitations
- Review; source-linked reaction identity is reused from existing local synthesis Findings. Does not establish a new competitive capacity constraint or benefit from increased intake.
- Evidence Source
- Inherited repository evidence
- Reference
- [2]
Evidence Dependency:
- Fernstrom transport evidence is reused, not independent replication of the human conversion study.
5. BRS Pathways and Connections
5.1 BRS Pathways
BRS1-FM1-PM1 — Amino-Acid Availability & Prioritisation ↓ BRS1-FM1-PM2 — LAT1 Competitive Transport Modulation ↓ BRS1-FM1-PM3 — Dopaminergic Signalling Regulation ↓ BRS1-FM1-PM4 — Noradrenergic Signalling
BRS1-FM1-PM1 — Amino-Acid Availability & Prioritisation ↓ BRS1-FM1-PM2 — LAT1 Competitive Transport Modulation ↓ BRS1-FM1-PM5 — Serotonergic Signalling Regulation
5.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS2(FM1) — Methylation Cycle Efficiency — Catecholamine inactivation can use COMT, which depends on SAM from one-carbon metabolism. The attached corpus does not establish that ordinary methylation-cycle variation controls noradrenaline signalling or attention.
5.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS1-FM1-PM1 - Amino-Acid Availability & Prioritisation — Supplies the circulating amino-acid pool, including tyrosine used on the catecholamine path to noradrenaline. Amino-acid quality and precursor-pool adequacy are assessed there. That is precursor supply, not noradrenaline signalling.
- BRS1-FM1-PM2 - LAT1 Competitive Transport Modulation — Governs competitive brain entry of large neutral amino acids, including tyrosine, after a meal. Transport bias is not noradrenaline synthesis or receptor signalling.
- BRS1-FM1-PM3 - Dopaminergic Signalling Regulation — Forms dopamine, the immediate precursor converted to noradrenaline, and shares the tyrosine-hydroxylase and decarboxylase steps. Dopaminergic signalling is not noradrenergic signalling.
- BRS1-FM1-PM5 - Serotonergic Signalling Regulation — Parallel monoamine path from shared precursor transport. It does not feed noradrenaline synthesis.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: High
- Evidence Confidence: Low–Medium
- Rationale: Noradrenaline helps set arousal and vigilance so attention and executive control can stay engaged O'Donnell et al. (2012) [1]. That biological role is not a dietary-treatment claim, and ADHD imaging that varies by dopamine process does not show a uniform noradrenaline deficit or a food-based attention effect MacDonald et al. (2024) [4].
Supporting evidence
The attached sources support noradrenaline as attention-relevant biology. They do not show that meals, iron or B6 change human noradrenaline signalling, and they do not show a uniform ADHD lesion that diet can correct.
What this means
Keep biological relevance separate from dietary modulation and from dopamine-process findings that are not noradrenaline measurements.
Evidence confidence: Not yet scored
Finding ID: PM4-F3
Finding Statement: Repository evidence supports a translational relationship from noradrenergic signalling to Focus / Attention Stability without establishing dietary modification of noradrenaline or an ADHD treatment effect.
Synthesised Evidence Confidence: Not yet scored
Synthesis: O’Donnell supplies the neuromodulatory attention and arousal account. MacDonald shows that ADHD-related catecholamine findings vary by process and method and cannot be restated as a single deficit. Fernstrom describes meal-level precursor transport upstream of signalling. Together they support a biology-to-attention mapping while blocking a food-as-noradrenaline-treatment reading.
Synthesis Limitations: No attached study measures attention after a dietary change aimed at noradrenaline. Plasma amino-acid ratios and dopamine-process reviews are not noradrenaline signalling.
Evidence Considered:
- Study
- Same mechanistic review used for PM4-F1, reused here for the attention-relationship proposition.
- Population
- Mixed mechanistic literature; not a dietary or ADHD-outcome sample.
- Result
- Supports attention-relevant signalling biology without a treatment or intake effect.
- Effect / Magnitude
- No clinical or dietary effect estimate.
- Evidence Summary
- Anchors the Phenome mapping in signalling biology.
- Limitations
- Review; no dietary or ADHD endpoint.
- Evidence Source
- Inherited repository evidence
- Reference
- [1]
- Study
- Critical review of the dopamine hypothesis in ADHD.
- Population
- Children and adults with ADHD, comparison groups and relevant animal models.
- Result
- Reported mixed dopamine-related findings rather than one directional lesion.
- Effect / Magnitude
- No pooled noradrenaline or dietary effect estimate.
- Evidence Summary
- Constrains ADHD wording attached to this Phenome relationship.
- Limitations
- Dopamine-focused; not a noradrenaline dietary trial.
- Evidence Source
- Inherited repository evidence
- Reference
- [4]
Connected / Supportive Evidence:
- Fernstrom (2013) [2] — MechanisticWhy relevant: Describes meal-level large-neutral-amino-acid transport that can change tyrosine presentation before catecholamine synthesis.Why excluded from the primary synthesis: Transport and plasma-ratio biology; it does not measure noradrenaline signalling or attention.
Evidence Dependency:
- O'Donnell et al. (2012) is also primary evidence in PM4-F1. Reuse here answers the Phenome-relationship proposition, not an independent replication of the signalling review.
- Fernstrom (2013) is connected evidence here and primary evidence in PM4-IC1. That is one transport review used for two propositions, not two independent studies.
Informs: Focus / Attention Stability
- Biology → Phenome Relationship Strength: Medium
- Evidence Confidence: Low–Medium
- Rationale: Noradrenaline can change arousal and effort-related tone, but dopaminergic reward circuitry remains the primary biological driver of Motivation / Drive MacDonald et al. (2024) [4]. The attached sources do not measure motivation after a dietary change, and iron-deficiency reviews are not motivation trials Beard et al. (2003) [3].
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low
- Rationale: Catecholamine systems can sit near reward and incentive-motivation biology, but the attached insulin–dopamine review does not measure noradrenaline signalling or a pleasure outcome after diet Gruber et al. (2023) [6]. Dopamine-process heterogeneity in ADHD is not a pleasure-capacity finding for this mechanism MacDonald et al. (2024) [4].
8. References
- [1] O'Donnell et al. (2012) — Norepinephrine
- [2] Fernstrom (2013) — LNAA Transport and Brain Neurochemistry
- [3] Beard et al. (2003) — Iron Deficiency Alters Brain Development and Functioning
- [4] MacDonald et al. (2024) — The Dopamine Hypothesis for ADHD
- [5] Santos et al. (2019) — Como o cérebro funciona?
- [6] Gruber et al. (2023) — Impact of Insulin and Insulin Resistance on Brain Dopamine Signalling and Reward
- [7] Kennedy (2016) — B Vitamins and Brain Function
- [8] Spector (1978) — Vitamin B6 Transport in the Central Nervous System
- [9] Goldstein and Eisenhofer (2026) — Catecholamine Metabolism Revisited
- [10] Vendelboe et al. (2016) — Human Dopamine β-Hydroxylase Structure
- [11] Scheiber, Mercer and Dringen (2014) — Copper in Brain
- [12] Lutsenko et al. (2019) — Copper and the Brain Noradrenergic System
- [13] Harrison and May (2009) — Vitamin C Function in the Brain
- [14] FAO (2013) — Dietary Protein Quality Evaluation in Human Nutrition
- [15] Mariotti and Gardner (2019) — Dietary Protein and Amino Acids in Vegetarian Diets
- [16] Gamo, Wang and Arnsten (2010) — Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors
- [17] Morón et al. (2002) — Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
- [18] Aston-Jones et al. (1994) — Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task
- [19] Froese et al. (2019) — Vitamin B12, Folate and Methionine Remethylation
- [20] Obeid (2013) — Metabolic Burden of Methyl Donor Deficiency
- [21] Bailey et al. (2021) — Human MAT2A ordered kinetic mechanism
- [22] Evans et al. (2002) — Human BHMT structure and catalytic zinc
- [23] Salvi and Gadda (2013) — Choline dehydrogenase and betaine formation
- [24] Lotta et al. (1995) — Human COMT kinetics and SAM-dependent catecholamine methylation
- [25] Møller et al. (2000) — Human Phenylalanine-to-Tyrosine Conversion
- [26] Wurtman et al. (1974) — Precursor Supply and Brain DOPA Synthesis